| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 32, 1551-1554, Copyright © 1986 by American Association for Clinical Chemistry
N Watanabe, S Kamei, A Ohkubo, M Yamanaka, S Ohsawa, K Makino and K Tokuda
In this new method for determining urinary protein, the reaction is complete within 10 min at 37 degrees C. This method is applicable to automated as well as manual measurements. Protein concentration and absorbance at 600 nm are linearly related throughout a wide range of concentrations, 10 to 16 000 mg/L. However, the chromogenicity of the gamma-globulins in this method is 70% of that of albumin, as estimated from results by a biuret method. Within-run CVs were less than 3.3%; the day-to-day CV was 2.9%. Errors due to interfering components in urine are less than 2%. The normal range for urinary protein as measured by this method was from 28 to 141 mg/day. Results by this method (y) and by a trichloroacetic acid-biuret method (x) correlated well (n = 80, r = 0.995; y = 0.99x - 2.9).
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  M. Guy, J. K Borzomato, R. G Newall, P. A Kalra, and C. P Price Protein and albumin-to-creatinine ratios in random urines accurately predict 24 h protein and albumin loss in patients with kidney disease Ann Clin Biochem, November 1, 2009; 46(6): 468 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Dhaun, I. M. MacIntyre, V. Melville, P. Lilitkarntakul, N. R. Johnston, J. Goddard, and D. J. Webb Blood Pressure-Independent Reduction in Proteinuria and Arterial Stiffness After Acute Endothelin-A Receptor Antagonism in Chronic Kidney Disease Hypertension, July 1, 2009; 54(1): 113 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J Lamb, F. MacKenzie, and P. E Stevens How should proteinuria be detected and measured? Ann Clin Biochem, May 1, 2009; 46(3): 205 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Guy, R. Newall, J. Borzomato, P. A. Kalra, and C. Price Use of a first-line urine protein-to-creatinine ratio strip test on random urines to rule out proteinuria in patients with chronic kidney disease Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1189 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Reusch, J. K. Murray, K. Papasouliotis, and S. P. Redrobe Urinary protein:creatinine ratio in rabbits in relation to their serological status to Encephalitozoon cuniculi Vet Rec., March 7, 2009; 164(10): 293 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Wenzel, T. Littke, S. Kuranoff, C. Jurgens, H. Bruck, E. Ritz, T. Philipp, A. Mitchell, and for the SPP301 (Avosentan) Endothelin Antagonist E Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria J. Am. Soc. Nephrol., March 1, 2009; 20(3): 655 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F De Somer, A Van Landschoot, G Van Nooten, and J Delanghe Interaction of plasma proteins with commercial protein repellent polyvinyl chloride (PVC): a word of caution Perfusion, July 1, 2008; 23(4): 215 - 221. [Abstract] [PDF]
|
|
|
|
 |
|
 D. J. Birmingham, B. H. Rovin, G. Shidham, M. Bissell, H. N. Nagaraja, and L. A. Hebert Relationship between Albuminuria and Total Proteinuria in Systemic Lupus Erythematosus Nephritis: Diagnostic and Therapeutic Implications Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1028 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Benck, S. Haeckel, J. H. Clorius, and F. J. van der Woude Proteinuria-Lowering Effect of Heparin Therapy in Diabetic Nephropathy without Affecting the Renin-Angiotensin-Aldosterone System Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 58 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Takakura, A. Takimoto, Y. Notsu, H. Yoshida, T. Ito, H. Nagatome, M. Ohno, Y. Kobayashi, T. Yoshioka, K. Inagaki, et al. Physicochemical and Pharmacokinetic Characterization of Highly Potent Recombinant L-Methionine {gamma}-Lyase Conjugated with Polyethylene Glycol as an Antitumor Agent. Cancer Res., March 1, 2006; 66(5): 2807 - 2814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Seagrave, A. Gigliotti, J. D. McDonald, S. K. Seilkop, K. A. Whitney, B. Zielinska, and J. L. Mauderly Composition, Toxicity, and Mutagenicity of Particulate and Semivolatile Emissions from Heavy-Duty Compressed Natural Gas-Powered Vehicles Toxicol. Sci., September 1, 2005; 87(1): 232 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Herzum, H. Renz, and H. G. Wahl Immunochemical Quantification of Free Light Chains in Urine Clin. Chem., June 1, 2005; 51(6): 1033 - 1035. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ofstad and B. M. Iversen Glomerular and tubular damage in normotensive and hypertensive rats Am J Physiol Renal Physiol, April 1, 2005; 288(4): F665 - F672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Maachi, S. Fellahi, A. Regeniter, M.-E. Diop, J. Capeau, J. Rossert, and J.-P. Bastard Patterns of Proteinuria: Urinary Sodium Dodecyl Sulfate Electrophoresis Versus Immunonephelometric Protein Marker Measurement Followed by Interpretation with the Knowledge-Based System MDI-LabLink Clin. Chem., October 1, 2004; 50(10): 1834 - 1837. [Full Text] [PDF]
|
|
|
|
|
|
T. Marshall and K. M. Williams Elimination of the Interference from Aminoglycoside Antibiotics in the Pyrogallol Red-Molybdate Protein Dye-Binding Assay Clin. Chem., September 1, 2004; 50(9): 1674 - 1675. [Full Text] [PDF]
|
|
|
|
|
|
Z. Yang, X. Sun, S. Li, Y. Tan, X. Wang, N. Zhang, S. Yagi, T. Takakura, Y. Kobayashi, A. Takimoto, et al. Circulating Half-Life of PEGylated Recombinant Methioninase Holoenzyme Is Highly Dose Dependent on Cofactor Pyridoxal-5'-Phosphate Cancer Res., August 15, 2004; 64(16): 5775 - 5778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Yilmaz, N. Celebi, and D. Yucel Automated Turbidimetric Benzalkonium Chloride Method for Measurement of Protein in Urine and Cerebrospinal Fluid Clin. Chem., August 1, 2004; 50(8): 1450 - 1452. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Oestvang, D. Bonnefont-Rousselot, E. Ninio, J. K. Hakala, B. Johansen, and M. W. Anthonsen Modification of LDL with human secretory phospholipase A2 or sphingomyelinase promotes its arachidonic acid-releasing propensity J. Lipid Res., May 1, 2004; 45(5): 831 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Marshall and K. M. Williams Extent of Aminoglycoside Interference in the Pyrogallol Red-Molybdate Protein Assay Depends on the Concentration of Sodium Oxalate in the Dye Reagent Clin. Chem., May 1, 2004; 50(5): 934 - 935. [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Caldwell and C. T. Lattemann Simple and Reliable Method To Precipitate Proteins from Bacterial Culture Supernatant Appl. Envir. Microbiol., January 1, 2004; 70(1): 610 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Sun, Z. Yang, S. Li, Y. Tan, N. Zhang, X. Wang, S. Yagi, T. Yoshioka, A. Takimoto, K. Mitsushima, et al. In Vivo Efficacy of Recombinant Methioninase Is Enhanced by the Combination of Polyethylene Glycol Conjugation and Pyridoxal 5'-Phosphate Supplementation Cancer Res., December 1, 2003; 63(23): 8377 - 8383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Marshall and K. M. Williams Aminoglycoside Interference in the Pyrogallol Red-Molybdate Protein Assay Is Increased by the Addition of Sodium Dodecyl Sulfate to the Dye Reagent Clin. Chem., December 1, 2003; 49(12): 2111 - 2112. [Full Text] [PDF]
|
|
|
|
|
|
J. R. Tate, D. Gill, R. Cobcroft, and P. E. Hickman Practical Considerations for the Measurement of Free Light Chains in Serum Clin. Chem., August 1, 2003; 49(8): 1252 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Anim-Nyame, J. Gamble, S. R. Sooranna, M. R. Johnson, and P. J. Steer Microvascular permeability is related to circulating levels of tumour necrosis factor-{alpha} in pre-eclampsia Cardiovasc Res, April 1, 2003; 58(1): 162 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Marshall and K. M. Williams Total Protein Determination in Urine: Aminoglycoside Interference Clin. Chem., January 1, 2003; 49(1): 202 - 203. [Full Text] [PDF]
|
|
|
|
|
|
J. Seagrave, J. D. McDonald, A. P. Gigliotti, K. J. Nikula, S. K. Seilkop, M. Gurevich, and J. L. Mauderly Mutagenicity and in Vivo Toxicity of Combined Particulate and Semivolatile Organic Fractions of Gasoline and Diesel Engine Emissions Toxicol. Sci., December 1, 2002; 70(2): 212 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bertram, N. Blanc-Brunat, J. Sassard, and M. Lo Differential evolution of blood pressure and renal lesions after RAS blockade in Lyon hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1041 - R1045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Cogo, L. J. I. Zimmermann, F. Rosso, F. Tormena, P. Gamba, G. Verlato, A. Baritussio, and V. P. Carnielli Surfactant Synthesis and Kinetics in Infants with Congenital Diaphragmatic Hernia Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 154 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Creamer, M. Allen, R. Jaggar, R. Stevens, R. Bicknell, and J. Barker Mediation of Systemic Vascular Hyperpermeability in Severe Psoriasis by Circulating Vascular Endothelial Growth Factor Arch Dermatol, June 1, 2002; 138(6): 791 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Chelliah, G. A. Sagnella, N. D. Markandu, and G. A. MacGregor Urinary Protein and Essential Hypertension in Black and in White People Hypertension, June 1, 2002; 39(6): 1064 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ogita, H. Okuda, M. Kitano, Y. Fujinami, K. Ozaki, and Y. Yoneda Localization of Activator Protein-1 Complex with DNA Binding Activity in Mitochondria of Murine Brain after In Vivo Treatment with Kainate J. Neurosci., April 1, 2002; 22(7): 2561 - 2570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bonnefont-Rousselot, E. Lehmann, M.-C. Jaudon, J. Delattre, B. Perrone, and J.-P. Rechke Blood oxidative stress and lipoprotein oxidizability in haemodialysis patients: effect of the use of a vitamin E-coated dialysis membrane Nephrol. Dial. Transplant., December 1, 2000; 15(12): 2020 - 2028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. McGinnity, A. J. Parker, M. Soars, and R. J. Riley Automated Definition of the Enzymology of Drug Oxidation by the Major Human Drug Metabolizing Cytochrome P450s Drug Metab. Dispos., November 1, 2000; 28(11): 1327 - 1334. [Abstract] [Full Text]
|
|
|
|
|
|
M. SHIOZAWA, A. P. PROVOOST, R. P. E. V. DOKKUM, R. R. MAJEWSKI, and H. J. JACOB Evidence of Gene--Gene Interactions in the Genetic Susceptibility to Renal Impairment after Unilateral Nephrectomy J. Am. Soc. Nephrol., November 1, 2000; 11(11): 2068 - 2078. [Abstract] [Full Text]
|
|
|
|
|
|
T. Marshall and K. M. Williams Total Protein Determination in Urine: Elimination of a Differential Response between the Coomassie Blue and Pyrogallol Red Protein Dye-binding Assays Clin. Chem., March 1, 2000; 46(3): 392 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Biou, J.-F. Benoist, C. Nguyen-Thi, X. Huong, P. Morel, and M. Marchand Cerebrospinal Fluid Protein Concentrations in Children: Age-related Values in Patients without Disorders of the Central Nervous System Clin. Chem., March 1, 2000; 46(3): 399 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F. McGinnity, S. J. Griffin, G. C. Moody, M. Voice, S. Hanlon, T. Friedberg, and R. J. Riley Rapid Characterization of the Major Drug-Metabolizing Human Hepatic Cytochrome P-450 Enzymes Expressed in Escherichia coli Drug Metab. Dispos., September 1, 1999; 27(9): 1017 - 1023. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. P C Hazenberg, P. C Limburg, J. Bijzet, and M. H van Rijswijk A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis Ann Rheum Dis, February 1, 1999; 58(2): 96 - 102. [Abstract] [Full Text]
|
|
|
|
|
|
M. Hemmelder, D. de Zeeuw, and P. de Jong Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease Nephrol. Dial. Transplant., January 1, 1999; 14(1): 98 - 104. [Abstract] [PDF]
|
|
|
|
|
|
T. Le Bricon, D. Erlich, D. Bengoufa, M. Dussaucy, J.-P. Garnier, and B. Bousquet Sodium dodecyl sulfate-agarose gel electrophoresis of urinary proteins: application to multiple myeloma Clin. Chem., June 1, 1998; 44(6): 1191 - 1197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pena, C. Martinez-Bru, R. Homs, T. Planella, and M. Cortes Effect of Plasma Replacement Therapy on Determinations of Urine Protein Concentration Clin. Chem., February 1, 1998; 44(2): 359 - 360. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Siegenthaler, K. Roulin, D. Chatellard-Gruaz, R. Hotz, J. H. Saurat, U. Hellman, and G. Hagens A Heterocomplex Formed by the Calcium-binding Proteins MRP8 (S100A8) and MRP14 (S100A9) Binds Unsaturated Fatty Acids with High Affinity J. Biol. Chem., April 4, 1997; 272(14): 9371 - 9377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Provoost, M. Shiozawa, R. P. E. Van Dokkum, and H. J. Jacob Transfer of the Rf-1 region from FHH onto the ACI background increases susceptibility to renal impairment Physiol Genomics, February 28, 2002; 8(2): 123 - 129. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
